Which pain block is best after breast surgery? new study aims to find out
NCT ID NCT07502846
First seen Apr 25, 2026 · Last updated Jun 22, 2026 · Updated 6 times
Summary
This study compares two types of nerve blocks (superficial vs. deep) for pain relief after breast surgery. 58 women will receive one of the two blocks, and researchers will measure how much pain medication they need in the first 24 hours. The goal is to find which block provides better pain control and reduces opioid use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE PAIN MANAGEMENT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Başakşehir Çam & Sakura City Hospital
Istanbul, Basaksehir, 34480, Turkey (Türkiye)
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
bupivacaine
What this could lead to
If one block works better, it could mean less pain and less need for strong painkillers after breast surgery.
What could go wrong
This is a small, early-stage study with only 58 people, so results may not apply to everyone. Both blocks are already used, so no major breakthrough is expected.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.